hoe 33342 has been researched along with Precursor Cell Lymphoblastic Leukemia-Lymphoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lizard, G; Lizard-Nacol, S; Maynadié, M; Poupon, MF; Roignot, P | 1 |
| Larsson, R; Nygren, P | 1 |
2 other study(ies) available for hoe 33342 and Precursor Cell Lymphoblastic Leukemia-Lymphoma
| Article | Year |
|---|---|
Evaluation of multidrug resistant phenotype by flow cytometry with monoclonal antibodies and functional tests.
Topics: Antibodies, Monoclonal; Antimetabolites, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzimidazoles; Daunorubicin; Drug Resistance, Multiple; Flow Cytometry; Fluorescent Antibody Technique; Fluorescent Dyes; Humans; Leukemia, Erythroblastic, Acute; Lymphoma, Non-Hodgkin; Phenotype; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Rhodamine 123; Rhodamines | 1995 |
Pharmacological modification of multi-drug resistance (MDR) in vitro detected by a novel fluorometric microculture cytotoxicity assay. Reversal of resistance and selective cytotoxic actions of cyclosporin A and verapamil on MDR leukemia T-cells.
Topics: Benzimidazoles; Cell Division; Cell Line; Cell Survival; Cyclosporins; Cytological Techniques; Dose-Response Relationship, Drug; Drug Resistance; Drug Screening Assays, Antitumor; Fluoresceins; Fluorescent Dyes; Fluorometry; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; T-Lymphocytes; Tumor Cells, Cultured; Verapamil; Vincristine | 1990 |